my account  log out
 

Coluracetam (MKC-231)

Create: 07/10/2019
Expired Date:12/31/2019
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:CAS No.:135463-81-9 Molecular Formula:C19H23N3O3 Molecular Weight:341.4042 Appearance:White Powder Origin:China Export Markets:Global Usage:Gain muscle and lean mass Storage:keep cool and dry,away from light Coluracetam is a nootropic drug of the racetam family. Coluracetam was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer's disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD), after being awarded a "Qualifying Therapeutic Discovery Program Grant" by the state of California. Findings from its Phase 2a clinical trials have suggested that it would be an ideal medication for co-morbid MDD with generalized anxiety disorder (GAD). BrainCells Inc is currently out-licensing the drug for this purpose. It may also have potential use in prevention and treatment of ischemic retinopathy and retinal and optic nerve injury. Coluracetam (MKC-231) is a synthetic Racetam drug purported to be a Nootropic compound. It does not have a large body of evidence investigating it, but the mechanisms of action (as well as structute) appear to be very distinct from other racetam compounds like Piracetam or Aniracetam. Web: www.rawsgear.com Web: www.rawsgearpharma.com Email: gear@quality-steroid.com Skype: +8615711952876 Whatsapp +8615711952876
City:Wuhan Hubei[CN] 
Location:
 
Jul 10 2019Clonidine hydrochloride296
Jul 10 2019Phenacetin283
Jul 10 2019CRL-40,940312
Jul 10 2019 Pregabalin (4-Methylpregabalin)300
Jul 10 2019Phenylacetonitrile290
Jul 10 2019DMBA (1,3-Dimethylbutylamine hydrochloride)296
Jul 10 2019DMHA (1,5-dimethyl-hexylamin)318
Jul 10 2019DMAA (1,3-Dimethylamylamine)327
Jul 10 2019Setipiprant300
Jul 10 20191,3-dimethyl-butylamine citrate300

return back

Copyright © toextrade Inc. All rights reserved. Contact us